Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 15

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 15
---
, but excluding restricted cash, if any, using, to the extent consistent therewith, the policies, conventions, methodologies and procedures used by the Company in preparing its unaudited financial statements. For the avoidance of doubt, (i) cash shall be increased by the amount of deposits or other payments received by the Company but not yet credited to the bank accounts of the Company, and (ii) cash shall be reduced by the amount of any outstanding checks or other payments issued by the Company but not yet deducted from the bank accounts of the Company; |

1

| • |     | “CD27 Asset Transfer” refers to the assignment and transfer of Kineta’s assets related to CD27 pursuant to the GigaGen Agreement; |

| • |     | “Certificates of Mergers” refers to the certificates of merger to filed with the Delaware Secretary of State to effect the Mergers; |

| • |     | “Change in Control Protection Period” refers to three (3) months immediately prior to and the twelve (12) months following the consummation of a change in control; |

| • |     | “Closing” refers to the completion of the Mergers and the transactions contemplated by the Merger Agreement; |

| • |     | “Closing Adjusted Cash Consideration” refers to a dollar amount equal to (i) Fifteen Million Dollars ($15,000,000), minus (ii) Five Million Dollars ($5,000,000) relating to TuHURA’s exclusivity payment under the Exclusivity Agreement, minus (iii) Three Hundred Thousand Dollars ($300,000) relating to TuHURA’s extension payment under the Exclusivity Agreement, minus (iv) Six Hundred Ninety-Five Thousand Dollars ($695,000) (relating to advances already made by TuHURA), minus (v) the Loaned Amount, if any, plus (vi) the Estimated Net Working Capital Surplus, if any, minus (vii) the Estimated Net Working Capital Deficit, if any; |

| • |     | “Closing Cash and Cash Equivalents” refers to the aggregate amount of all Cash and Cash Equivalents of the Company as of 12:01 a.m. Eastern Time on the Closing Date; |

| • |     | “Closing Date” refers to the date on which the Closing occurs; |

| • |     | “Closing Liabilities and Debt” refers to aggregate amount of all Liabilities and Debt of the Company as of 12